NovaBay Common Stock vs Cash And Short Term Investments Analysis

NBY Stock  USD 0.53  0.06  10.17%   
NovaBay Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating NovaBay Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NovaBay Pharmaceuticals is a good investment. Please check the relationship between NovaBay Pharmaceuticals Common Stock and its Cash And Short Term Investments accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NovaBay Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.

Common Stock vs Cash And Short Term Investments

Common Stock vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NovaBay Pharmaceuticals Common Stock account and Cash And Short Term Investments. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between NovaBay Pharmaceuticals' Common Stock and Cash And Short Term Investments is 0.45. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of NovaBay Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of NovaBay Pharmaceuticals' Common Stock and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of NovaBay Pharmaceuticals are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Common Stock i.e., NovaBay Pharmaceuticals' Common Stock and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.45
Relationship DirectionPositive 
Relationship StrengthWeak

Common Stock

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of NovaBay Pharmaceuticals balance sheet. This account contains NovaBay Pharmaceuticals investments that will expire within one year. These investments include stocks and bonds that can be liquidated by NovaBay Pharmaceuticals fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Most indicators from NovaBay Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NovaBay Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NovaBay Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.Selling General Administrative is likely to rise to about 7.5 M in 2024, whereas Tax Provision is likely to drop 0.00 in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit5.6M7.8M7.9M8.1M
Total Revenue8.4M14.4M14.7M10.0M

NovaBay Pharmaceuticals fundamental ratios Correlations

0.83-0.37-0.190.330.450.150.170.33-0.61-0.25-0.160.730.640.630.50.60.370.870.590.30.23-0.110.12-0.190.0
0.83-0.11-0.340.15-0.110.0-0.20.28-0.76-0.04-0.40.790.340.740.540.530.290.880.620.330.20.06-0.21-0.29-0.18
-0.37-0.110.080.06-0.49-0.44-0.45-0.230.25-0.09-0.56-0.31-0.02-0.38-0.33-0.41-0.15-0.39-0.3-0.180.380.550.07-0.07-0.43
-0.19-0.340.080.280.220.090.62-0.060.3-0.26-0.32-0.25-0.17-0.31-0.33-0.53-0.14-0.16-0.3-0.41-0.40.35-0.160.880.07
0.330.150.060.280.350.090.60.360.17-0.90.05-0.050.48-0.250.390.230.520.070.260.260.47-0.05-0.210.270.01
0.45-0.11-0.490.220.350.260.630.120.06-0.340.370.050.6-0.030.050.230.20.160.1-0.060.03-0.290.570.150.24
0.150.0-0.440.090.090.260.48-0.27-0.35-0.060.290.37-0.350.28-0.10.1-0.360.34-0.15-0.16-0.28-0.33-0.280.20.03
0.17-0.2-0.450.620.60.630.480.320.24-0.610.25-0.060.09-0.190.06-0.030.290.060.00.08-0.08-0.18-0.190.650.36
0.330.28-0.23-0.060.360.12-0.270.320.14-0.37-0.040.10.270.130.450.090.950.210.380.750.44-0.17-0.190.020.55
-0.61-0.760.250.30.170.06-0.350.240.14-0.390.22-0.910.0-0.93-0.35-0.430.21-0.86-0.490.190.270.160.080.240.17
-0.25-0.04-0.09-0.26-0.9-0.34-0.06-0.61-0.37-0.39-0.060.16-0.430.42-0.29-0.18-0.510.06-0.08-0.42-0.630.050.21-0.22-0.13
-0.16-0.4-0.56-0.320.050.370.290.25-0.040.22-0.06-0.240.05-0.230.180.410.03-0.290.140.09-0.04-0.650.13-0.220.23
0.730.79-0.31-0.25-0.050.050.37-0.060.1-0.910.16-0.240.050.920.450.430.00.910.490.01-0.04-0.32-0.13-0.250.13
0.640.34-0.02-0.170.480.6-0.350.090.270.0-0.430.050.05-0.030.340.480.490.210.460.230.490.020.57-0.29-0.11
0.630.74-0.38-0.31-0.25-0.030.28-0.190.13-0.930.42-0.230.92-0.030.370.330.00.890.45-0.01-0.22-0.27-0.08-0.250.11
0.50.54-0.33-0.330.390.05-0.10.060.45-0.35-0.290.180.450.340.370.780.520.420.760.420.33-0.48-0.25-0.30.33
0.60.53-0.41-0.530.230.230.1-0.030.09-0.43-0.180.410.430.480.330.780.20.450.750.30.24-0.410.0-0.49-0.04
0.370.29-0.15-0.140.520.2-0.360.290.950.21-0.510.030.00.490.00.520.20.150.40.780.59-0.12-0.07-0.050.41
0.870.88-0.39-0.160.070.160.340.060.21-0.860.06-0.290.910.210.890.420.450.150.510.15-0.07-0.1-0.14-0.08-0.02
0.590.62-0.3-0.30.260.1-0.150.00.38-0.49-0.080.140.490.460.450.760.750.40.510.190.09-0.28-0.08-0.310.05
0.30.33-0.18-0.410.26-0.06-0.160.080.750.19-0.420.090.010.23-0.010.420.30.780.150.190.64-0.08-0.28-0.220.26
0.230.20.38-0.40.470.03-0.28-0.080.440.27-0.63-0.04-0.040.49-0.220.330.240.59-0.070.090.64-0.110.09-0.460.14
-0.110.060.550.35-0.05-0.29-0.33-0.18-0.170.160.05-0.65-0.320.02-0.27-0.48-0.41-0.12-0.1-0.28-0.08-0.11-0.010.41-0.69
0.12-0.210.07-0.16-0.210.57-0.28-0.19-0.190.080.210.13-0.130.57-0.08-0.250.0-0.07-0.14-0.08-0.280.09-0.01-0.3-0.06
-0.19-0.29-0.070.880.270.150.20.650.020.24-0.22-0.22-0.25-0.29-0.25-0.3-0.49-0.05-0.08-0.31-0.22-0.460.41-0.3-0.03
0.0-0.18-0.430.070.010.240.030.360.550.17-0.130.230.13-0.110.110.33-0.040.41-0.020.050.260.14-0.69-0.06-0.03
Click cells to compare fundamentals

NovaBay Pharmaceuticals Account Relationship Matchups

NovaBay Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets11.2M15.2M24.0M16.4M9.0M14.4M
Total Stockholder Equity973K12.3M10.2M10.6M3.3M5.3M
Other Assets477K912K476K489K562.4K461.6K
Common Stock Shares Outstanding618.3K28.6K35.6K46K120.4K125.5K
Liabilities And Stockholders Equity11.2M15.2M24.0M16.4M9.0M14.4M
Other Stockholder Equity125.7M148.0M150.9M165.1M176.1M88.1M
Total Liab10.2M2.9M13.8M5.8M5.7M7.1M
Other Current Liab993K1.7M763K667K1.0M1.3M
Total Current Liabilities5.7M2.8M3.4M4.3M4.3M4.1M
Property Plant And Equipment Net1.4M520K604K2.0M1.4M1.0M
Net Debt(2.9M)(11.4M)(7.0M)(3.3M)(390K)(409.5K)
Retained Earnings(125.0M)(136.1M)(141.9M)(158.2M)(174.8M)(166.1M)
Accounts Payable331K302K1.0M1.1M1.1M812.7K
Cash6.9M12.0M7.5M5.4M3.1M6.0M
Non Current Assets Total1.8M996K10.8M5.1M1.9M2.0M
Cash And Short Term Investments6.9M12.0M7.5M5.4M3.1M3.0M
Common Stock Total Equity154K171K279K418K480.7K263.6K
Other Current Assets105K576K778K560K388K463.4K
Property Plant And Equipment Gross1.4M520K1.2M2.6M2.1M1.1M
Total Current Assets9.4M14.2M13.2M11.3M7.2M9.5M
Accumulated Other Comprehensive Income(243K)(509K)(560K)(275K)(247.5K)(259.9K)
Common Stock279K418K478K652K112K106.4K
Property Plant Equipment110K520K604K2.0M1.8M1.8M
Other Liab2.5M560K4.1M10.1M11.6M12.2M
Current Deferred Revenue822K730K1.3M1.8M946K1.2M
Non Current Liabilities Total4.6M87K10.4M1.6M1.4M2.6M
Short Term Debt3.5M832K505K906K2.1M2.2M
Non Currrent Assets Other77K2K476K489K497K300.0K
Net Receivables1.1M1.1M1.7M2.0M759K721.1K
Net Tangible Assets5.0M973K12.3M(237K)(213.3K)(202.6K)
Retained Earnings Total Equity(111.1M)(115.0M)(125.0M)(136.1M)(122.5M)(116.3M)
Capital Surpluse125.7M148.0M150.9M165.1M189.8M118.8M
Inventory492K608K3.2M3.4M2.9M3.0M
Non Current Liabilities Other198K4.6M561K334K300.6K285.6K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for NovaBay Stock Analysis

When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.